无扁桃体肥大的阻塞性睡眠呼吸暂停患儿家庭使用共享决策工具后的临床结局
这项前瞻性单盲随机对照试验纳入50个转诊至多学科上气道中心的患儿家庭(24例研究组、26例对照组),评估共享决策工具(SDMT)对无扁桃体肥大的阻塞性睡眠呼吸暂停(OSA)患儿临床结局的影响。结果显示,使用SDMT的家庭与医生就最佳治疗方案达成一致的比例更高(91.7% vs 46.2%,P<0.001),随访前修改治疗计划的比例更低(0% vs 15.4%,P=0.04),研究组阻塞性呼吸暂停低通气指数中位数显著改善(从13.4降至3.5次/小时,P=0.01),对照组无显著改善。
要点
- 使用SDMT后医患就最佳治疗方案达成一致的比例为91.7%,对照组为46.2%(P<0.001)。
- 对照组4例(15.4%)在首次随访前修改治疗计划,研究组无修改(P=0.04)。
- 研究组阻塞性呼吸暂停低通气指数中位数从13.4降至3.5次/小时(P=0.01),对照组无显著改善。
核心结论
- 对于无扁桃体肥大的OSA患儿家庭,使用SDMT进行治疗方案咨询后,家庭更可能接受已达成一致的治疗,且CPAP依从性更高。
研究设计与样本
- 前瞻性单盲随机对照试验,连续纳入转诊至多学科上气道中心的患者,研究组使用SDMT,对照组不使用,随访至下一次预约和多导睡眠图检查,共评估50个家庭(研究组24例,对照组26例),证据等级1b。
主要发现
- 初次就诊后,研究组24例中22例(91.7%)与医生就最佳治疗方案达成一致,对照组26例中12例(46.2%)达成一致(P<0.001)。
- 首次随访前,对照组4个家庭(15.4%)修改治疗计划,研究组无家庭修改(P=0.04)。
- CPAP依从性在研究组为57%(5/8),对照组为27%(3/11)(P=0.11)。
- 研究组阻塞性呼吸暂停低通气指数中位数从13.4(范围20.0-57.2)降至3.5(范围0.4-45.5)次/小时(P=0.01),对照组从9.4(范围0.9-76.2)降至4.9(范围0-116)次/小时(P=0.10),无显著改善。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine if shared decision-making tools (SDMTs) improve clinical outcomes for these children. Shared decision making (SDM) is a collaborative process in which patients and clinicians jointly establish treatment plans that integrate clinical evidence and patient values/preferences. We previously reported less decisional conflict using a SDMT for families of children with obstructive sleep apnea (OSA) without tonsillar hypertrophyl; however, the clinical impact of this finding is unknown. METHODS: Prospective single-blind randomized controlled trial for consecutive patients referred to a multidisciplinary upper airway center. The study group used a SDMT, whereas the control group did not; all were followed until their next appointment and polysomnogram. RESULTS: We assessed 50 families (24 study, 26 controls); mean age of patients was 8.8 (95% confidence interval 6.9-10.6) years, and 44% were female. After their initial visit, there was agreement between families and providers on the best treatment option for 22 of 24 (91.7%) study patients and 12 of 26 (46.2%) controls (P < 0.001). Before the first follow-up, four control families (15.4%) modified their treatment plan, whereas none of the study families did so (P = 0.04). Continuous positive airway pressure (CPAP) compliance was 27% (3 of 11) for controls and 57% (5 of 8) for study patients (P = 0.11). The median obstructive apnea-hypopnea index significantly improved in study patients from 13.4 (range, 20.0-57.2) to 3.5 (range 0.4-45.5, P = 0.01] events per hour, but not in controls, with 9.4 (range, 0.9-76.2) to 4.9 (range, 0-116, P = 0.10) events per hour. CONCLUSION: Families of children with OSA without tonsillar hypertrophy who were counseled regarding treatment options using SMDTs were more likely to undergo agreed upon treatment and had higher CPAP compliance. LEVEL OF EVIDENCE: 1b. Laryngoscope, 129:2646-2651, 2019.
引用
- Bergeron M, Duggins A, Chini B, et al. Clinical outcomes after shared decision-making tools with families of children with obstructive sleep apnea without tonsillar hypertrophy. Laryngoscope. 2019. PMID: 30618048. doi:10.1002/lary.27653
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。